|
CSNK1G3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.70809999999944E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.236900E-04 |
| Normal-vs-Stage2 |
1.560830E-03 |
| Normal-vs-Stage3 |
2.19530000000745E-06 |
| Normal-vs-Stage4 |
1.21710000000608E-06 |
| Stage1-vs-Stage2 |
5.503000E-01 |
| Stage1-vs-Stage3 |
4.459900E-02 |
| Stage1-vs-Stage4 |
3.135700E-02 |
| Stage2-vs-Stage3 |
4.152400E-01 |
| Stage2-vs-Stage4 |
2.165400E-01 |
| Stage3-vs-Stage4 |
5.490000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.01980000000313E-05 |
| Normal-vs-AfricanAmerican |
2.271700E-02 |
| Normal-vs-Asian |
2.580300E-04 |
| Caucasian-vs-AfricanAmerican |
6.721800E-01 |
| Caucasian-vs-Asian |
6.585600E-01 |
| AfricanAmerican-vs-Asian |
4.842400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.387080E-04 |
| Normal-vs-Female |
5.72189999999972E-05 |
| Male-vs-Female |
9.433000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.857500E-03 |
| Normal-vs-Age(41-60Yrs) |
1.87271999999572E-05 |
| Normal-vs-Age(61-80Yrs) |
2.28390000001077E-06 |
| Normal-vs-Age(81-100Yrs) |
6.726300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.194100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.353600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.502800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.747400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.796600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.090600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.357800E-02 |
| Classical-VS-Follicular |
1.065620E-02 |
| Classical-VS-Other |
7.258800E-01 |
| Classical-VS-Normal |
1.944180E-03 |
| Tall-VS-Follicular |
5.533600E-01 |
| Tall-VS-Other |
4.114000E-01 |
| Tall-VS-Normal |
2.1016999999901E-05 |
| Follicular-VS-Other |
6.222800E-01 |
| Follicular-VS-Normal |
3.00369999994832E-06 |
| Other-VS-Normal |
1.014200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.65180000003085E-06 |
| Normal-vs-N1 |
1.390240E-04 |
| N0-vs-N1 |
8.302200E-01 |
|
|
